A new partnership is helping a KU Innovation Park company move one step closer to large-scale production.
Love Lifesciences has partnered with Excite Pharma Services to validate its robotic syringe fill-finish system at Excite’s FDA-registered manufacturing facility in Lee’s Summit, Mo. The collaboration marks an important milestone as the company prepares its proprietary manufacturing platform for commercial-scale aseptic production.
Why it matters
Validation is a critical step between innovation and commercialization.
Once complete, the automated system will be capable of producing more than 10,000 prefilled syringes per day with a single technician, helping reduce manufacturing costs while expanding access to Love Lifesciences’ patented UNIPEN injection platform.
What they’re building
Love Lifesciences develops the UNIPEN® Injection Platform, a patented injection safety device and manufacturing system designed for pharmaceutical manufacturers and compounding pharmacies.
As part of the partnership:
- The robotic fill finish system has been installed at Excite Pharma Services.
- The companies will complete installation, operational and performance qualification, along with cleaning validation and media fill studies.
- Following validation, the partners plan to jointly market both the manufacturing system and the UNIPEN platform.
In their words
“Our engineers have put years of hard work into every stage of our manufacturing here in Kansas, from the earliest prototypes to a platform now capable of high volume output with minimal technician effort,” said Bradley Hopper, co-founder and chief technology officer of Love Lifesciences. “Partnering with Excite gives us the chance to prove out these efforts in a real production setting, and we’re excited about what it means for the growth of UNIPEN and the life sciences footprint in this region.”
The bigger picture
Moving a medical technology from concept to commercial production takes more than a great idea. It requires the right manufacturing partners, regulatory expertise and validation processes to ensure products are ready for market.
This collaboration represents another important commercialization milestone for Love Lifesciences as it continues growing its manufacturing capabilities while advancing innovative injection technologies developed here in Kansas.
Photo: Love Lifesciences Regulatory & Quality Specialist, Colby Spiess (left) & CTO, Bradley Hopper (right) with Robotic Fill-Finish. Photo courtesy Love Lifesciences.


















